Deprecated (16384): The ArrayAccess methods will be removed in 4.0.0.Use getParam(), getData() and getQuery() instead. - /home/brlfuser/public_html/src/Controller/ArtileDetailController.php, line: 150
 You can disable deprecation warnings by setting `Error.errorLevel` to `E_ALL & ~E_USER_DEPRECATED` in your config/app.php. [CORE/src/Core/functions.php, line 311]
Deprecated (16384): The ArrayAccess methods will be removed in 4.0.0.Use getParam(), getData() and getQuery() instead. - /home/brlfuser/public_html/src/Controller/ArtileDetailController.php, line: 151
 You can disable deprecation warnings by setting `Error.errorLevel` to `E_ALL & ~E_USER_DEPRECATED` in your config/app.php. [CORE/src/Core/functions.php, line 311]
Warning (512): Unable to emit headers. Headers sent in file=/home/brlfuser/public_html/vendor/cakephp/cakephp/src/Error/Debugger.php line=853 [CORE/src/Http/ResponseEmitter.php, line 48]
Warning (2): Cannot modify header information - headers already sent by (output started at /home/brlfuser/public_html/vendor/cakephp/cakephp/src/Error/Debugger.php:853) [CORE/src/Http/ResponseEmitter.php, line 148]
Warning (2): Cannot modify header information - headers already sent by (output started at /home/brlfuser/public_html/vendor/cakephp/cakephp/src/Error/Debugger.php:853) [CORE/src/Http/ResponseEmitter.php, line 181]
LATEST NEWS UPDATES | Despite no cap 'indication', govt put knee implant under price limit -Deepak Patel

Despite no cap 'indication', govt put knee implant under price limit -Deepak Patel

Share this article Share this article
published Published on Jun 13, 2018   modified Modified on Jun 13, 2018
-The Indian Express

The Department of Industrial Policy and Promotion (DIPP) and the NPPA are also documented as having given similar assurances in subsequent meetings.

New Delhi:
After the National Pharmaceutical Pricing Authority (NPPA) imposed price caps on coronary stents in February last year, the Prime Minister’s Office (PMO) is documented as having “indicated” to representatives of foreign medical device companies in a meeting that the Indian government has no plans to expand price controls to other devices such as knee implants. The Department of Industrial Policy and Promotion (DIPP) and the NPPA are also documented as having given similar assurances in subsequent meetings.

However, on August 16, 2017, the NPPA capped the prices of knee implants in an “immediate intervention” to “check unethical profiteering and exploitative pricing at the cost of the patients in an unregulated market”. Moreover, when asked about the assurance given to foreign medical device companies last year, the DIPP told The Indian Express that “there is no question of any assurance being given” by its “officials” and “any such statement is baseless”.

The details of the meetings were mentioned in an e-mail sent by Abby Pratt, vice-president, Global Strategy and Analysis, Advanced Medical Technology Association (AdvaMed) to the office of the United States Trade Representative (USTR) on September 8, 2017. Washington DC-based AdvaMed primarily represents US medical device, pharma and tech majors such as Abbott, Boston Scientific Corporation, Medtronic, BD, Pfizer, GlaxoSmithKline, Apple and Microsoft. India’s medical device technology market is worth about $6 billion, and is expected to grow to $50 billion by 2025. India imports around 80 per cent of its medical devices, a quarter of it from companies based in the US.

In her e-mail, Pratt wrote the timeline of dialogue of foreign medical device industry with the Indian government on price controls. Pratt wrote that a group of industry officials — which she termed as “APACMed mission to India” — met Anurag Jain, Joint Secretary, PMO, “among others” on May 4 or May 5 of 2017. Pratt wrote: “During the meeting, the PMO indicated that the Indian government had no plans to expand price controls”. Many members of APACMed (Asia Pacific Medical Technology Association) are US-based companies, which are members of AdvaMed too. Jain did not respond to the queries sent by The Indian Express.

Please click here to read more.

The Indian Express, 12 June, 2018, http://indianexpress.com/article/business/business-others/despite-no-cap-indication-govt-put-knee-implant-under-price-limit-5213449/lite/


Related Articles

 

Write Comments

Your email address will not be published. Required fields are marked *

*

Video Archives

Archives

share on Facebook
Twitter
RSS
Feedback
Read Later

Contact Form

Please enter security code
      Close